4//SEC Filing
Fleming Michael 4
Accession 0001104659-19-027601
CIK 0000310158other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:32 PM ET
Size
13.5 KB
Accession
0001104659-19-027601
Insider Transaction Report
Form 4
Fleming Michael
SVP Chief Ethics & Com Officer
Transactions
- Exercise/Conversion
Common Stock
2019-05-04+692→ 2,045.829 total - Award
Stock Option (right to buy)
2019-05-03+11,291→ 11,291 totalExercise: $80.00From: 2020-05-03Exp: 2029-05-02→ Common Stock (11,291 underlying) - Tax Payment
Common Stock
2019-05-04$80.00/sh−238$19,040→ 1,807.829 total - Exercise/Conversion
Restricted Stock Unit
2019-05-04$80.00/sh−692$55,360→ 1,386 totalFrom: 2019-05-04Exp: 2021-05-04→ Common Stock (692 underlying) - Award
Restricted Stock Unit
2019-05-03+1,500→ 1,500 totalFrom: 2020-05-03Exp: 2022-05-03→ Common Stock (1,500 underlying)
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
- [F5]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001772183
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 8:32 PM ET
- Size
- 13.5 KB